Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
about
Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Endocarditis and myocarditis: a brief review.Herpes simplex virus-induced cardiomyopathy successfully treated with acyclovir.Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.
P2860
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@ast
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@en
type
label
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@ast
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@en
prefLabel
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@ast
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@en
P2093
P2860
P1476
Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.
@en
P2093
C M Lawson
G R Shellam
P2860
P304
P356
10.1128/AAC.45.5.1444-1449.2001
P407
P577
2001-05-01T00:00:00Z